The TST involves the intradermal injection of purified protein derivative (PPD) from the tuberculosis bacterium. This test is designed to trigger a delayed-type hypersensitivity reaction in individuals who have been sensitized to the antigen, either through infection or previous vaccination with the BCG vaccine.
